Published in Cancer Discovery, early trials show that sevabertinib can shrink tumours in patients with HER2 exon 20, a mutated lung cancer found in roughly 2-3 per cent of cases.
Harshil Dave, a researcher at IIT Gandhinagar, co-authored the paper with his colleagues Hitasha Vithalani, Hemant Singh, Indu Yadav, and Abhinav Jain, among others.
The Global Cancer Observatory predicts that cancer cases will rise to 32.6 million worldwide by 2045, with India already carrying the third-highest cancer burden globally.
Experts say ‘surge in cancer cases remains relatively modest on a per capita basis, but actual burden may be higher due to persistent underreporting in rural, underserved regions’.
Cancer imposes catastrophic health expenditure in India, with medicines constituting over 60% of out-of-pocket expenditure. Research shows wide price variations, limited cost containment.
Study published in Nature Cell Biology is fundamental in understanding the ways in which cancer cells can develop drug resistance, one of the main causes of relapse.
Pakistan's SSG team was not adequately provisioned for the inclement weather. If it managed to consolidate its position, the story of Siachen would have been different.
The reopening of the Strait of Hormuz eases supply fears, but controlled shipping, slow output recovery, and high costs may delay oil flow normalisation for months.
This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS